Unapproved drug use: compassionate or cause for concern?
Ross
Emma
E
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003365:Costs and Cost Analysis; D017277:Drug Approval; D004358:Drug Therapy / Q000706:statistics & numerical data / Q000639:trends*; D064420:Drug-Related Side Effects and Adverse Reactions; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use; D010344:Patient Advocacy; D012306:Risk; D000077236:Topiramate; D014481:United States / Q000453:epidemiology
D000927:Anticonvulsants; D018020:Lithium Compounds; D000077236:Topiramate; D005632:Fructose